TY  - JOUR 
AU  - Peleteiro Vigil, Ana
AU  - Ortiz Rivero, Sara
AU  - Izquierdo Mateo, Yanira
AU  - Sánchez Vicente, Laura
AU  - González Sánchez, María Ester
AU  - Vaquero, Javier
AU  - Arévalo Martín, Juan Carlos
AU  - Briz Sánchez, Oscar
AU  - Monte Río, María Jesús
AU  - García Marín, José Juan
AU  - Herráez Aguilar, Elisa
PY  - 2026
SN  - 1671-4083
UR  - http://hdl.handle.net/10366/172480
AB  - [EN] Cholangiocarcinoma (CCA) is a biliary cancer with a poor prognosis and marked chemoresistance. The transcription factor SOX17, which is essential for cholangiocyte differentiation, is frequently downregulated in CCA, as is the case with several...
LA  - eng
PB  - Springer Nature Limited
KW  - Cell therapy
KW  - Cell-penetrating peptides
KW  - Drug delivery
KW  - Gene therapy
KW  - Liver cancer
KW  - SOXF Transcription Factors
KW  - Cholangiocarcinoma
KW  - Bile Ducts
KW  - Cell Proliferation
KW  - Genes, Tumor Suppressor
TI  - Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study
DO  - 10.1038/s41401-026-01881-y
T2  - Acta Pharmacologica Sinica
ER  -